CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder

Julia Richter1, Ilske Oschlies1, Katharina Kock1

  • 1Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Kiel, Germany.

The Journal of Pathology
|November 7, 2023
PubMed
Summary

Primary cutaneous CD4+ small or medium T-cell lymphoproliferative disorder (PCSM-LPD) shows distinct molecular features compared to aggressive Tfh lymphomas. CD70 pathway activation may drive the benign proliferation of PCSM-LPD.